# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060299
Filing Date
2025-04-29
Accepted
2025-04-29 17:00:24
Documents
19
Period of Report
2025-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | eldn-20250429.htm iXBRL | DEF 14A | 1075096
2 | GRAPHIC | img118025896_0.jpg | GRAPHIC | 191772
3 | GRAPHIC | img118025896_1.jpg | GRAPHIC | 959267
4 | GRAPHIC | img118025896_2.jpg | GRAPHIC | 935638
5 | GRAPHIC | img118025896_3.jpg | GRAPHIC | 1388381
6 | GRAPHIC | img118025896_4.jpg | GRAPHIC | 147454
| Complete submission text file | 0000950170-25-060299.txt |  | 10594200

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20250429.xsd | EX-101.SCH | 12025
22 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20250429_htm.xml | XML | 393409

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 25888950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)